The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

INTRODUCTION: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are associated with favorable response in EGFR mutant lung cancer. Acquired resistance to reversible EGFR TKIs remains a significant barrier, and acquired EGFR T790M-mutation is the major mechanism. Second-genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shang-Gin, Liu, Yi-Nan, Tsai, Meng-Feng, Chang, Yih-Leong, Yu, Chong-Jen, Yang, Pan-Chyr, Yang, James Chih-Hsin, Wen, Yueh-Feng, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914294/
https://www.ncbi.nlm.nih.gov/pubmed/26862733
http://dx.doi.org/10.18632/oncotarget.7189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914294/
https://www.ncbi.nlm.nih.gov/pubmed/26862733
http://dx.doi.org/10.18632/oncotarget.7189

Ejemplares similares